Physician

Carlo E Gopez, M.D

According to 2025 Medicare claims, Carlo Gopez, M.D (NPI: 1578770004) practices family practice in the Wilmington, DE-MD-NJ market, with the plurality of this provider's patient population coming from Cecil, MD. This provider's primary affiliated billing organization is MERIDIAN PRIMARY CARE LLC (NPI: 1689881120; TIN: 300417199) and primary practice location at 21921-5326. Gopez is affiliated with the Aledade 200 Chesapeake MSSP Enhanced (ACO ID: A5365), participating under the MSSP model.

Gopez's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 415 traditional Medicare patients, billed 2,471 HCPCS/CPT codes, and received $138,423 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 7,649 prescription claims across 459 beneficiaries totaling $714,947 in drug costs, led by Humira Pen (Adalimumab). DME data shows 389 claims. Open Payments data shows 64 records totaling $1,331. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $166,129 to $138,423. In contrast, Part D prescription costs have risen steadily, from $422,140 to $714,947. For DME billing, this smaller-volume category moved up and down with repeated peaks and valleys, starting at $16,890 and ending at $28,971.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	507	2,752	$166,129
2016	558	3,243	$208,573
2017	558	2,684	$173,434
2018	586	2,765	$176,841
2019	547	2,671	$173,175
2020	468	1,717	$104,620
2021	477	2,029	$144,984
2022	472	2,129	$154,862
2023	431	1,967	$145,423
2024	415	2,471	$138,423

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	370	7,128	$422,140
2016	433	7,110	$459,691
2017	450	7,751	$541,793
2018	469	8,032	$602,707
2019	493	8,859	$632,177
2020	444	7,835	$594,367
2021	431	6,643	$547,227
2022	465	7,207	$650,827
2023	455	7,058	$768,309
2024	459	7,649	$714,947

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	139	653	$14,522
2016	131	723	$19,657
2017	126	678	$16,968
2018	113	701	$19,040
2019	115	638	$15,325
2020	130	597	$13,311
2021	154	454	$14,352
2022	87	405	$12,569
2023	101	464	$15,545
2024	105	389	$19,292

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	115	115	$130
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	381	932	$84
90653	Influenza vaccine, inactivated	126	126	$81
G0008	Administration of influenza virus vaccine	135	137	$32
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	333	644	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira Pen	Adalimumab	13	364	$88,550
Jardiance	Empagliflozin	70	4,448	$88,065
Eliquis	Apixaban	60	3,785	$70,947
Mounjaro	Tirzepatide	26	896	$31,737
Januvia	Sitagliptin Phosphate	39	1,357	$26,288

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	22	$7,707
A7030	Full face mask used with positive airway pressure device, each	N	N/R	22	$1,696
A7032	Cushion for use on nasal mask interface, replacement only, each	N	N/R	14	$1,585
A7031	Face mask interface, replacement for full face mask, each	N	N/R	18	$1,511
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	20	$1,483

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	64	$1,331	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Carlo E. Gopez, M.D?

Tedicare shows public-source Medicare data for Carlo E. Gopez, M.D (NPI 1578770004), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Carlo E. Gopez, M.D have ACO affiliation data?

Carlo E. Gopez, M.D is shown with ACO affiliation data for Aledade 200 Chesapeake MSSP Enhanced (MSSP, ACO ID A5365).

What billing organization is linked to Carlo E. Gopez, M.D?

Carlo E. Gopez, M.D is linked to MERIDIAN PRIMARY CARE LLC (billing NPI 1689881120) in the available physician profile data.

Does Carlo E. Gopez, M.D have Open Payments data?

Carlo E. Gopez, M.D has 64 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.